Found: 17
Select item for more details and to access through your institution.
DNAJA1- and conformational mutant p53-dependent inhibition of cancer cell migration by a novel compound identified through a virtual screen.
- Published in:
- Cell Death Discovery, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41420-022-01229-5
- By:
- Publication type:
- Article
Novel compound C150 inhibits pancreatic cancer through induction of ER stress and proteosome assembly.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.870473
- By:
- Publication type:
- Article
Novel Compound C150 Inhibits Pancreatic Cancer Cell Epithelial-to-Mesenchymal Transition and Tumor Growth in Mice.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.773350
- By:
- Publication type:
- Article
Activity-Based Protein Profiling Reveals That Cephalosporins Selectively Active on Non-replicating Mycobacterium tuberculosis Bind Multiple Protein Families and Spare Peptidoglycan Transpeptidases.
- Published in:
- Frontiers in Microbiology, 2020, v. 11, p. 1, doi. 10.3389/fmicb.2020.01248
- By:
- Publication type:
- Article
Effect of C-2 substitution on the stability of non-traditional cephalosporins in mouse plasma.
- Published in:
- Journal of Antibiotics, 2019, v. 72, n. 6, p. 469, doi. 10.1038/s41429-019-0167-y
- By:
- Publication type:
- Article
Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 441, p. 1, doi. 10.1126/scitranslmed.aap8307
- By:
- Publication type:
- Article
VCP inhibitors induce endoplasmic reticulum stress, cause cell cycle arrest, trigger caspase-mediated cell death and synergistically kill ovarian cancer cells in combination with Salubrinal.
- Published in:
- Molecular Oncology, 2016, v. 10, n. 10, p. 1559, doi. 10.1016/j.molonc.2016.09.005
- By:
- Publication type:
- Article
Targeting p97 to Disrupt Protein Homeostasis in Cancer.
- Published in:
- Frontiers in Oncology, 2016, p. 1, doi. 10.3389/fonc.2016.00181
- By:
- Publication type:
- Article
A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.
- Published in:
- Journal of Neuroscience, 2016, v. 38, n. 28, p. 7441, doi. 10.1523/JNEUROSCI.0636-16.2016
- By:
- Publication type:
- Article
Cover Picture: Evaluating p97 Inhibitor Analogues for Potency against p97-p37 and p97-Npl4-Ufd1 Complexes (ChemMedChem 9/2016).
- Published in:
- ChemMedChem, 2016, v. 11, n. 9, p. 948, doi. 10.1002/cmdc.201600214
- By:
- Publication type:
- Article
Evaluating p97 Inhibitor Analogues for Potency against p97-p37 and p97-Npl4-Ufd1 Complexes.
- Published in:
- ChemMedChem, 2016, v. 11, n. 9, p. 953, doi. 10.1002/cmdc.201600036
- By:
- Publication type:
- Article
Threading the Needle: Small-Molecule Targeting of a Xenobiotic Receptor to Ablate Escherichia coli Polysaccharide Capsule Expression Without Altering Antibiotic Resistance.
- Published in:
- 2016
- By:
- Publication type:
- journal article
N-Phenylbenzamides as Potent Inhibitors of the Mitochondrial Permeability Transition Pore.
- Published in:
- ChemMedChem, 2016, v. 11, n. 3, p. 283, doi. 10.1002/cmdc.201500545
- By:
- Publication type:
- Article
Discovery, Synthesis, and Optimization of Diarylisoxazole-3-carboxamides as Potent Inhibitors of the Mitochondrial Permeability Transition Pore.
- Published in:
- ChemMedChem, 2015, v. 10, n. 10, p. 1655, doi. 10.1002/cmdc.201500284
- By:
- Publication type:
- Article
Evaluating p97 Inhibitor Analogues for Their Domain Selectivity and Potency against the p97-p47 Complex.
- Published in:
- ChemMedChem, 2015, v. 10, n. 1, p. 52, doi. 10.1002/cmdc.201402420
- By:
- Publication type:
- Article
Structure-Activity Relationship Study Reveals ML240 and ML241 as Potent and Selective Inhibitors of p97 ATPase.
- Published in:
- ChemMedChem, 2013, v. 8, n. 2, p. 297, doi. 10.1002/cmdc.201200520
- By:
- Publication type:
- Article
Identification and analysis of hepatitis C virus NS3 helicase inhibitors using nucleic acid binding assays.
- Published in:
- Nucleic Acids Research, 2012, v. 40, n. 17, p. 8607, doi. 10.1093/nar/gks623
- By:
- Publication type:
- Article